Congratulations to Dr. Corina Schneidawind for receiving a competitive Gileat/Kite grant on "Human CRISPR/Cas9 leukemia platforms to transit molecular-guided treatment strategies from proof-of-concept to clinical routine"
Congratulations to Dr. Corina Schneidawind for receiving a competitive Gileat/Kite grant on "Human CRISPR/Cas9 leukemia platforms to transit molecular-guided treatment strategies from proof-of-concept to clinical routine"